Sort   by:  
 Page size 
BACKGROUND. Improving and predicting tumor response to immunotherapy remains challenging. Combination therapy with a transforming growth factor β (TGF-β) inhibitor that targets cancer associated fibroblasts (CAFs) is promising to enhance efficacy of cancer immunotherapies. However, the effect of thi...
ORGANISM(S): Mus musculus 
2023-12-19 | GSE247303 | GEO
Sort   by:  
 Page size